Literature DB >> 16912489

The Almodin-Moron trocar for uterine entry during fetal surgery.

C G Almodin1, A F Moron, S Cavaliero, A Yamashita, W Hisaba, J Piassi.   

Abstract

OBJECTIVE: Compare the use of a newly designed and reusable metal trocar for initial uterine entry with the disposable Tulipan-Bruner trocar in creation of a hysterotomy for fetal surgery.
METHODS: Six consecutive patients undergoing hysterotomy for intrauterine repair of myelomeningocele were randomized to uterine entry either with the Tulipan-Bruner trocar or with the Almodin-Moron trocar. Blood loss was estimated by the primary surgeon.
RESULTS: There was no statistically significant difference in the uterine entry times between the trocars. Blood loss was estimated to be approximately the same. The Almodin-Moron trocar was judged to provide easy handling with good safety.
CONCLUSIONS: The Almodin-Moron trocar provides a uterine entry during creation of a hysterotomy that is as quick and causes as little trauma as the Tulipan-Bruner trocar. 2006 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2006        PMID: 16912489     DOI: 10.1159/000093882

Source DB:  PubMed          Journal:  Fetal Diagn Ther        ISSN: 1015-3837            Impact factor:   2.587


  3 in total

Review 1.  Prenatal versus postnatal repair procedures for spina bifida for improving infant and maternal outcomes.

Authors:  Rosalie M Grivell; Chad Andersen; Jodie M Dodd
Journal:  Cochrane Database Syst Rev       Date:  2014-10-28

2.  Fetal hydrocephalus.

Authors:  Sergio Cavalheiro; Antonio Fernandes Moron; Carlos Gilberto Almodin; Italo Capraro Suriano; Vagner Hisaba; Patricia Dastoli; Mauricio Mendes Barbosa
Journal:  Childs Nerv Syst       Date:  2011-09-17       Impact factor: 1.475

Review 3.  Understanding Sociodemographic Disparities in Maternal-Fetal Surgery Study Participation.

Authors:  Abigail Wilpers; Anna Y Lynn; Barbara Eichhorn; Amy B Powne; Megan Lagueux; Janene Batten; Mert Ozan Bahtiyar; Cary P Gross
Journal:  Fetal Diagn Ther       Date:  2022-03-10       Impact factor: 2.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.